Designing a Prospective COVID-19 Therapeutic with Reinforcement Learning
원문 초록
The SARS-CoV-2 pandemic has created a global race for a cure. One approach focuses on designing a novel variant of the human angiotensin-converting enzyme 2 (ACE2) that binds more tightly to the SARS-CoV-2 spike protein and diverts it from human cells. Here we formulate a novel protein design framework as a reinforcement learning problem. We generate new designs efficiently through the combination of a fast, biologically-grounded reward function and sequential action-space formulation. The use of Policy Gradients reduces the compute budget needed to reach consistent, high-quality designs by at least an order of magnitude compared to standard methods. Complexes designed by this method have been validated by molecular dynamics simulations, confirming their increased stability. This suggests that combining leading protein design methods with modern deep reinforcement learning is a viable path for discovering a Covid-19 cure and may accelerate design of peptide-based therapeutics for other diseases.
함께 살펴볼 논문
공통 태그를 근거로 연결했습니다. 실제 인용 관계나 논문의 우수성을 뜻하지 않습니다.
Margin Trader: A Reinforcement Learning Framework for Portfolio Management with Margin and Constraints
Task Independent Capsule-Based Agents for Deep Q-Learning
A State Representation Dueling Network for Deep Reinforcement Learning
Drafting in Collectible Card Games via Reinforcement Learning
Self-Driving Network and Service Coordination Using Deep Reinforcement Learning
Social-Aware Incentive Mechanism for VehicularCrowdsensing by Deep Reinforcement Learning
토론
이 논문과 연결된 포럼 글이 아직 없습니다.